Class IIITerminatedD-0314-2021
Drug recall · April 7, 2021
Tremfya recall
Why: Temperature Abuse
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.
- Lots / codes
KESOY.AI Exp. 04/2022
- Quantity
- 48 boxes
- Company
- Cardinal Health Inc., Dublin, OH
- Distribution
- AL, LA, MS, TN
- Initiated
- March 9, 2021 · Voluntary: Firm initiated
- Classified
- March 29, 2021
- Reported
- April 7, 2021
- Ended
- November 4, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tremfya
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.